Benzinga | Feb 25, 2021 07:06AM EST

Aclaris Therapeutics Q4 EPS $(0.30) Up From $(0.45) YoY, Sales $1.58M Up From $1.09M YoY

Aclaris Therapeutics (NASDAQ:ACRS) reported quarterly losses of $(0.30) per share. This is a 33.33 percent increase over losses of $(0.45) per share from the same period last year. The company reported $1.58 million in sales this quarter. This is a 44.29 percent increase over sales of $1.09 million the same period last year.